Episode
TJM Labs and Pharmacists in Politics | TWIRx
- Podcast
- Pharmacy Podcast Network
- Published
- May 1, 2026
- Duration seconds
- 2920
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/pharmacy-podcast-network-945715/episodes/tjm-labs-and-pharmacists-in-politics-twirx/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/pharmacy-podcast-network-945715/tjm-labs-and-pharmacists-in-politics-twirx.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Congratulations to Logan Eury and his new wife Emily, got married today, May 1, 2026! This C.O. Bigelow Collab Introduces the 188-Year-Old Pharmacy to a New Generation Abbode is taking over the Carolyn Bessette-Kennedy-approved shop for a month-long pop-up.https://fashionista.com/2026/05/co-bigelow-abbode-pop-up-carolyn-bessette-impact The article highlights how a pop-up and renewed interest in C.O. Bigelow has been fueled by the cultural resurgence of Carolyn Bessette-Kennedy’s minimalist style, amplified by media and social buzz. This renewed attention has driven significant foot traffic and sales, showing how storytelling, nostalgia, and “quiet luxury” aesthetics can translate into real retail impact. Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit https://www.managedhealthcareexecutive.com/view/q-a-mayo-clinic-leaders-share-strategies-for-managing-high-cost-drugs-without-breaking-the-bank-asembia-axs26-summitMayo Clinic leaders emphasize that managing high-cost drugs requires clear definitions, structured formulary review processes, and multidisciplinary collaboration to balance cost, access, and clinical value. They highlight the importance of evaluating safety, efficacy, financial impact, and site-of-care decisions together, while noting that non-340B systems face increasing pressure from rising costs and reimbursement constraints. Ultimately, success depends on stronger alignment between health systems, manufacturers, and payers to sustain access without compromising quality of care. Where Gross-to-net Pressure Actually Lives After LaunchToday’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx.https://www.drugchannels.net/2026/05/where-gross-to-net-pressure-actual…